Professional Documents
Culture Documents
-ADITYA VERMA
CERTIFICATE OF ACHIEVEMENT
SIGNATURE OF SIGNATURE OF
PRINCIPLE TEACHER
------------------------ ------------------------
INDEX
Introduction
Drugs
Classification of drugs
Therapeutic action of different classes of drugs
Tranquillizer
Minor tranquilizers
Major tranquilizers
Organic compositions
Effects of tranquilizer
Bibliography
Introduction
Since antiquity, people of virtually every culture have used chemical
substances to induce sleep, relieve stress, alleviate anxiety, and manage
the crippling symptoms of severe mental illness. Although clinical
descriptions of psychotic patients—especially schizophrenics—date
back to at least 1400 B.C., prior to 1950, effective drugs for the
treatment of psychotic patients were virtually nonexistent. Reserpine,
an alkaloid, and the active ingredient of Rauwolfia serpentine, the
Indian snakeroot, was the basis of the first major tranquilizer. Reserpine
was used in the treatment of snake bites, high blood pressure, and
anxiety. Rauwolfia was long used in India for the treatment of mental
illness (especially paranoia and schizophrenia) and known to medicine
men and locals as the "insanity herb." And although the plant was well
known in India—Gandhi sometimes sipped tea made from its leaves—
Westerners paid little attention to it until an Indian physician wrote an
article about it in 1943.
After a U.S. physician named Wilkins demonstrated the positive effects
of reserpine in 1952, the drug gained instant notoriety. Reserpine
rapidly replaced induced insulin shock therapy (injecting patients with
insulin until their blood sugar levels fall so low that the they become
comatose), electroconvulsive (ECT) therapy (inducing seizures by
passing an electric current through the brain), and lobotomy (making
an incision in the lobe of the brain) as treatments for certain types of
mental illness. Moreover, knowledge about the chemistry of this
natural plant stimulated the synthesis of other similar alkaloids that
were later used as major tranquilizers.
The advent of neuroleptics is sometimes identified as a turning point in
the practice of psychiatry because it made possible for the first time the
treatment and control of mentally ill people outside an institutional
setting. In most developed countries, a large percentage of the people
suffering, or in remission, from psychosis are treated in the community.
This community-based treatment depends almost entirely on dosing
with neuroleptics. However, since their discovery, the use of
neuroleptics has fueled an ongoing debate within the mainstream
psychiatric community. This discussion arises primarily as a result of
the serious nature and unpredictability of side effects associated with
these drugs. The first sedative-hypnotic, or minor tranquilizer,
bromide, originated in the 1860s. Bromides are long-acting sedatives
that were rarely used past the turn of the nineteenth century; however,
bromide can still be found in Broom Seltzer. The bromides are gastric
irritants with a narrow safety margin and may cause a chronic toxicity
known as bromes.
Barbiturates (a class of drugs with more effective sedative-hypnotic
effects) replaced bromides in 1903. Depending on the dose, frequency,
and duration of use, however, tolerance, physical dependence, and
psychological dependence on barbiturates can occur relatively rapidly.
With the development of tolerance, the margin of safety between the
effective dose and the lethal dose becomes very narrow. That is, in
order to obtain the same level of intoxication, the tolerant abuser may
raise his or her dose to a level that can produce coma and death.
DRUGS
CLASSIFICATION OF DRUGS
Drugs are mainly classified on criteria as given below
On the bases of pharmacological effect
This classification based on pharmacological effect of the drugs. It
is useful for doctors because it provides them the whole range of
drugs available for the treatment of a particular type of problem. For
example, analgesics have pain killing effect, antiseptic kill or arrest
the growth of microorganisms.
On the basis of drug action
It is based on the action of a drugs on a particular biochemical
process. For example, all antihistamines inhibit the action of the
compound, histamine which causes inflammation in the body. There
are various ways in which action of histamines can be blocked.
On the basis of chemical structure
It is based on the chemical structure of the drugs. Drugs classified in
this way share common structure feature and often have similar
pharmacological activity.
On the basis of molecular targets
Drugs usually interact with biomolecules such as carbohydrates,
lipids, proteins, and nucleic acid. These are called target molecule or
drugs targets. Drugs possessing some common structural feature
may have the same mechanism of action on targets. The
classification based on molecular targets is the most useful
classification for medical chemist.
Tranquillizer
Tranquilizers are agents that suppress or inhibit some aspects of
central nervous system (CNS) activity—the brain, spinal cord, and
the nerves from both—and are thus referred to as CNS depressants.
Used primarily to treat insomnia as well as a wide variety of anxiety
disorders, tranquilizers are among the most commonly prescribed—
and abused—psychiatric medications in the United States.
According to Food and Drug Administration (FDA) estimates, over
60 million people receive prescriptions for tranquilizers every year.
As a group, tranquilizers act mostly on the brain by affecting the
neurotransmitter gamma-amino butyric acid (GABA).
Neurotransmitters are brain chemicals that facilitate communication
between brain cells (neurons). Although the various classes of CNS
depressants work in different ways, ultimately it is through their
ability to increase GABA activity (thereby decreasing brain activity)
that they produce a drowsy or calming effect that is beneficial to
those suffering from anxiety or sleep disorders. Although a wide
variety of substances can have tranquilizing effects, historically, the
term "major tranquilizer" was applied to the category of drugs used
to treat severe mental illnesses such as schizophrenia. This term,
however, arose from the inaccurate belief that the major positive
action of the earliest drugs used to treat this illness was sedating and
that these drugs were on a continuum with other, less powerful,
antianxiety drugs.
However, these drugs are now more commonly—and more
accurately—called neuroleptics or antipsychotics. As opposed to
medications prescribed for sedation, the neuroleptics often produce
signs of neurological dysfunction, such as extrapyramidal effects
(involuntary movements such as Parkinson-like tremors and other
abnormal movements). The term "antipsychotics" is sometimes used
because these drugs are generally used to treat symptoms of
paranoia, psychosis, or serious distortions in the perception of
reality, such as hallucinations or delusions. The neuroleptics are not
typically drugs of abuse.
Minor tranquilizers (sedative hypnotics/anxiolytics)
sleep
relieve stress
feel euphoria or pleasurable sensations
escape/avoidance—unpleasant sensations, tension, fear, or
anxiety
enhance effects of other narcotic drugs or alcohol
offset effects of stimulant drugs
haloperidol (Haldol)
thiothixene (Novae)
trifluoperazine (Stalinize)
mesoridazine (Serenity)
thioridazine (Mallari)
chlorpromazine (Thiazine)
CHEMICAL/ORGANIC COMPOSITION
Effects of tranquilizer
MENTAL EFFECTS
The most significant beneficial mental effects of the major
and minor tranquilizers include: anxiety reduction, mild
euphoria, panic reduction
PHYSIOLOGICAL EFFECTS
Beneficial physiological effects of the major and minor
tranquilizers include: anesthesia, anticonvulsant effects,
blood vessel dilation, and decreased contractibility of the
heart, decreased hyperactivity, impulsivity, and aggression,
muscle relaxation, pain relief, reduced muscle spasms,
relaxation, sedation, slowed heart rate
Harmful side effects
At high doses, both the major and minor tranquilizers are
severely toxic and may cause coma, respiratory arrest,
convulsions, acute renal failure, speech impairment, or
death. However, at therapeutic doses, the neuroleptics have
been associated with more severe, long-term side effects
than the sedative-hypnotics.
Major tranquilizers
Although long-term studies are few, the adverse side effects
of the atypical neuroleptics are thought to be less severe
than the typical agents. However, adverse side effects have
been reported with all neuroleptics. These side effects
include: agitation and confusion, cardiac symptoms,
dyskinesia of the face and tongue, extrapyramidal
symptoms, moderate respiratory depression with increased
bronchial secretions, postural hypotension, sedation, and
weight gain.
Minor tranquilizers
Some of the most commonly reported adverse effects of the
sedative-hypnotics, particularly when used long-term,
include: blurred and double vision, compromised
mechanical performance, depression, dizziness,
hallucinations, hostility, impaired mental alertness,
thinking, and memory, paradoxical reactions, especially in
children, adults with brain disease, and the elderly, rebound
anxiety or insomnia.
Google.in
NCERT book part 2
NCERT book part 1
www. Scribd.com